The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
European Journal of Cancer · 2024
DOI: 10.1016/j.ejca.2023.113441 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Adriana Hepner und 27 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma Institute Australia, The University of Sydney, NSW, Australia; Instituto do Cancer do Estado de Sao Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Melanoma Institute Australia, National Computational Infrastructure.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Melanoma Institute Australia, The University of Sydney, NSW, Australia; Instituto do Cancer do Estado de Sao Paulo, SP, Brazil.
- Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.
- Sir Peter MacCallum Cancer Centre Department of Oncology, The University of Melbourne, Melbourne, Australia.
- Université Paris Cite, Dermato-Oncology AP-HP Hôpital Saint Louis, INSERM U976, F-75010 Paris, France.
- Crown Princess Mary Cancer Centre Westmead and Blacktown Hospitals, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
- Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
Förderung
- NCI NIH HHS
- Melanoma Institute Australia
- National Computational Infrastructure
- Nicholas and Helen Moore and Melanoma Institute Australia
- National Health and Medical Research Council
- Conquer Cancer Foundation
- University of Sydney
Zitieren
APA
Hepner, A., Versluis, J. M., Wallace, R., Allayous, C., Brown, L. J., Trojaniello, C., Gerard, C. L., Jansen, Y. J., Bhave, P., Neyns, B., Haydon, A., Michielin, O., Mangana, J., Klein, O., Shoushtari, A. N., Warner, A. B., Ascierto, P. A., McQuade, J. L., Carlino, M. S., …, & Menzies, A. M. (2024). The features and management of acquired resistance to PD1-based therapy in metastatic melanoma. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113441
Vancouver
Hepner A, Versluis JM, Wallace R, Allayous C, Brown LJ, Trojaniello C, et al. The features and management of acquired resistance to PD1-based therapy in metastatic melanoma. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2023.113441
BibTeX
@article{Hepner2024,
author = {Hepner, Adriana and Versluis, Judith M and Wallace, Roslyn and Allayous, Clara and Brown, Lauren Julia and Trojaniello, Claudia and Gerard, Camille Lea and Jansen, Yanina Jl and Bhave, Prachi and Neyns, Bart and Haydon, Andrew and Michielin, Olivier and Mangana, Joanna and Klein, Oliver and Shoushtari, Alexander N and Warner, Allison Betof and Ascierto, Paolo Antonio and McQuade, Jennifer Leigh and Carlino, Matteo S and Zimmer, Lisa and Lebbe, Celeste and Johnson, Douglas B and Sandhu, Shahneen and Atkinson, Victoria and Blank, Christian U and Lo, Serigne N and Long, Georgina V and Menzies, Alexander M},
title = {The features and management of acquired resistance to PD1-based therapy in metastatic melanoma},
journal = {European Journal of Cancer},
year = {2024},
doi = {10.1016/j.ejca.2023.113441}
}
EUVIMED